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ABSTRACT 
 
Prostate (PR) cancer (CA) is one of the most common malignant neoplasms in men all over the world. In general, if 
prostate cancer (PC) is detected early, treatment usually involves either surgical removal of the prostate or 
radiotherapy (RT). Hormone Therapy (HT) or chemotherapy (CH) is the preferred treatment for more advanced 
cases of PC or if CA spreads beyond the PT. A number of complications, such as urinary incontinence (IU) or 
erectile dysfunction (ED), can be associated with some modalities of treatment of the PC. The aim of this work is to 
evaluate, in PubMed, the number of publications related with prostate cancer and the main modalities of treatment, 
as well as some clinical complications. The searches were performed in PubMed 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) in the period 1950 to 2008 using the words: (i) CA, (ii) CA and PR 
or penis or testis, (iii) CA and PR and RT, CA and PR and surgery (SU), CA and PR and CH and, CA and PR and 
HT and (iv) CA and PR and RT and IU or ED, CA and PR and SU and IU or ED, CA and PR and CH and IU or ED 
and, CA and PR and HT and CH and IU or ED, and (V) PC and the same modalities of treatment. The data was 
obtained on July 20th, 2008. PC, as expected has been cited extensively and surgery has been identified as the most 
widely referenced modality of treatment. Furthermore, urinary incontinence and erectile dysfunction are important 
complications that have attracted significant scientific interest.  In conclusion, these findings have shown the 
relevance of the PubMed to analyze quantitatively the publications in cancer and this information could be 
worthwhile in aiding the comprehension of some clinical aspects related with PC, as well as the development of 
preventative actions. The analysis of the scientific interest, considering the number of publications in the PubMed, 
reveals research trends in the field and demonstrates the importance of the surgical procedures in the treatment of 
the prostate cancer. Moreover, this finding is relevant due to the fact that surgery is the treatment of choice when 
early detection of PC is achieved. However, it is important to consider clinical complications related to such 
procedures, such as urinary incontinence and erectile dysfunctions that can reduce the quality of life of the patient. 
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INTRODUCTION 
 
Prostate (PR) cancer (CA) is one of the most 
common malignant neoplasm in men all over the 
world (Antilla et al., 2005), as well as in Brazil 
(http://www.inca.gov.br/estimativa/2008/finalversi
on.pdf) in particular and is the third most common 
cancer worldwide and the most common cancer in 
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the North American continent (Boulikas, 2008; 
http://info.cancerresearchuk.org/cancerstats/geogra
phic/world/commoncancers/). Despite prostate 
cancer’s high incidence, relatively little is known 
of its etiology. Long asymptomatic period and 
slow growth rate of the tumor have hampered 
studies on the etiologic hypotheses (Antilla et al., 
2005). Prostate cancer incidence rates are still 
increasing steadily (Neutel et al., 2007) and 
worldwide disparities exist between geographic 
regions with regards to prostate cancer (PC) 
incidence and mortality. Countries in East Asia 
have lower rates of PC compared to Western 
countries such as Canada and the United States 
(Goetzl et al., 2007), although the incidence of PC 
has been increasing in recent years in China (Song 
et al., 2007). The large difference between the 
incidence of PC and the mortality associated with 
this disease suggests that a large number of men 
do not require treatment (Albertsen, 2006). 
Prostate cancer is rare below age 40, with 
incidence rates doubling each subsequent decade 
of life after that. Family history and ethnicity/ 
country of residence are the only firmly 
established risk factors for PC (Antilla et al., 
2005). Schimid et al., 2007 reported that other risk 
factors for PC include increasing age, ethnic 
origin, and familial/hereditary factors. Yet, the 
epidemiology of PC gives some indications that its 
etiology is probably not only genetic, but also 
environmental.  
Prostate cancer is an ideal candidate for exogenous 
preventive measures, such as dietary and 
pharmacological prevention, due to some specific 
features associated with the disease: high 
prevalence, long latency, endocrine dependency, 
availability of serum markers and histological 
precursor lesions (Schimid HP et al., 2007). Some 
authors  (Schimid et al., 2007; Goetzl et al., 2007) 
have reported that dietary/nutritional factors that 
may influence disease development include total 
energy intake, dietary fat, cooked meat, 
micronutrients and vitamins, fruit and vegetable 
intake, minerals and phytoestrogens. 
Prostate cancer preferentially metastasizes to 
regional lymph nodes and bone. The incidence of 
metastasis has been reduced over the last years, 
mainly due to early detection based on the 
determination of prostate-specific-antigen (PSA) 
(Garin, 2006), as well as the digital rectal 
examination, transrectal ulstrasonography (TRUS) 
and TRUS-guided biopsies (Futterer et al., 2008). 
Imaging techniques help the diagnosis of diseases 
in general (Lomeña and Soler, 2005) and play a 
central role in the detection, localization, staging, 
and local recurrence detection in patients who 
suffer from PC (Futterer et al., 2008). The 
modalities for the treatment of PC depend on the 
stage of the disease, the age of the individual and 
the presence of other clinical conditions. In 
general, if PC is detected early, treatment usually 
involves either surgical removal of the prostate or 
radiotherapy (RT). For more advanced cases of 
PC, or, if cancer spreads beyond the prostate, 
hormone therapy (HT) or chemotherapy (CT) are 
the treatments of choice. (Pendleton et al., 2007). 
Relevant complications, as urinary incontinence or 
erectile dysfunction, can be associated with some 
treatment modalities of PC (Escudero et al., 2006; 
Zagar et al., 2007). Chatoor et al. (2007) reported 
that radical prostatectomy and radiotherapy of PC 
could also cause of fecal incontinence. 
PubMed is a service of the U.S. National Library 
of Medicine that includes over 16 million 
MEDLINE citations and other life science journals 
for biomedical articles back to the 1950s. PubMed, 
which is used as a tool in various publications, 
includes links to full text articles and other related 
resources. Garg et al (2006) have used medical 
literature databases including PubMed to compile 
and review data on radiation proctopathy in the 
treatment of prostate cancer with respect to 
epidemiology, clinical manifestations, risk factors, 
pathogenesis, and treatment. Nishino et al., 2006, 
have evaluated the association between tobacco 
smoking and gastric cancer risk among the 
Japanese population, based on a systematic review 
of epidemiologic evidence and original data were 
collected by searches of MEDLINE using 
PubMed, complemented by manual searches. 
As the increasing interest of the scientific 
community in oncology is evident worldwide, the 
aim of this work is to evaluate, in the PubMed, the 
number of publications related to PC, the main 
modalities of treatment and possible complications 
associated with the treatments, as well as look at 
trends in the research and therapeutic directions 
related with this disease. This information could 
be useful in developing actions for the prevention 
of prostate cancer, as well as in understanding and 
discussing the therapeutic modalities available for 
PC and informing patients about the possible 
clinical disorders associated with these treatments. 
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MATERIAL AND METHODS 
 
The searches were performed in PubMed 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) 
for the period 1950 to 2008 using the words: (i) 
cancer (CA), (ii) CA and PR, (iii) CA and testis 
and (iv) CA and penis.  
A search using the words CA and PR were 
associated with the modalities of treatment, RT or 
surgery (SG) or CT or HT. Moreover, another 
search using the words “prostate cancer” (PC), 
also associated with the modalities of treatment, 
was performed to evaluate consistency. 
Statistical analysis involved Chi-Squared Test, 
with a significance level of P<0.05, was performed 
comparing the searches using “CA and PR and 
modalities of treatment” and “PC and modalities 
of treatment”. InStat Graphpad software was used 
to perform statistical analysis (GraphPad InStat 
version 3.01 for Windows 95/NT, GraphPad 
Software, San Diego Ca, USA).  
Another search was performed using (a) CA and 
PR and RT and urinary incontinence (UI) or 
erectile dysfunction (ED), (b) CA and PR and SG 
and UI or ED, (c) CA and PR and CT and UI or 
ED or anal incontinence (AI) and (d) CA and PR 
and HT and CT and UI or ED or AI.  
Finally, a search using the above parameters was 
performed for the same date of the years 1968, 
1978, 1988, 1998 and 2008 to decipher any trends 
associated with preferred choices of treatment as 
new modalities become available. The data were 
obtained on July 20th, 2008 and the number of 
citations for each subject was determined. 
 
 
RESULTS 
 
Table 1 shows the number of publications found in 
the PubMed on CA as well as CA and various 
organs of the male reproductive tract. The results 
show a high number of publications in cancer, of 
which nearly 3% are associated with PR. 
Table 2 shows the number of publications cited in 
the PubMed on CA and PT and the main 
modalities of treatment, as well as PC and the 
same modalities of treatment. Surgery has been 
shown to be the modality of treatment associated 
with prostate cancer that is most widely cited 
when compared with RT, CT and HT, whilst RT 
and HT are the least cited ones. The comparison 
between CA and PT and PC was very significant 
(P<0.01) in all modalities of treatment. 
 
Table 1- Number of publications cited in PubMed on CA, as well as, CA and various organs of the male 
reproductive tract. 
Selected subject Number of publications 
CA 2174533 
CA and PR 63560 
CA and testis 12212 
CA and penis 4745 
 
 
Table 2 - Comparison of the number of publications cited in PubMed on CA and PT and the main modalities of 
treatment, as well as PC and the same modalities of treatment. 
Subject CA and PT PC 
RT 8585 5467 
SG 18531 11226 
CT 11867 8234 
HT 8202 5936 
 
 
Table 3 shows the number of publications cited in 
the PubMed on some complications associated 
with modalities of treatment for PC. Urinary 
incontinence and erectile dysfunction have been 
mainly associated with surgery.  
The number of publications involving prostate 
cancer and the studied modalities of treatment with 
anal (fecal) incontinence is very poor.  
Table 4 shows the number of publications found in 
PubMed on CA and PR and the main therapeutic 
modalities in order to demonstrate changes in the 
trends of research and publications on PC 
treatments within the last 50 years. 
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Table 3 - Number of publications cited in PubMed on some complications associated with modalities of treatment 
for prostate cancer. 
Subject Number of publications 
CA and PR and RT and UI 233 
CA and PR and RT and ED 299 
CA and PR and SG and UI 558 
CA and PR and SG and ED 523 
CA and PR and CT and UI 43 
CA and PR and CT and ED 159 
CA and PR and HT and UI 28 
CA and PR and HT and ED 106 
 
 
 
Table 4 - Number of publications cited in PubMed on CA and PR and the main modalities of treatment over the past 
50 years. 
Year CA and PR and 
RT 
CA and PR and 
CH 
CA and PR and 
SG 
CA and PR and 
HT 
1968 57 60 359 254 
1978 235 419 1016 573 
1988 797 1427 2540 1446 
1998 2623 3826 7388 3328 
2008 8585 11867 18531 8202 
 
 
DISCUSSION 
 
Although mortality from prostate cancer has been 
declining over the past decade, metastasis, which 
is presented in approximately 20% of patients, can 
substantially shorten survival time and remains a 
major challenge in maintaining quality of life for 
survivors (Choueiri et al., 2006; Kabeer et al., 
2007). As reported by Schimid et al. 2007, prostate 
cancer is basically an ideal candidate for 
exogenous preventive measures, such as dietary 
and pharmacological prevention. Moreover, 
Schimid et al. (2007) and Goetzl et al. (2007) have 
also reported that dietary/nutritional factors may 
influence the disease development. These 
scientific considerations are worthwhile in order to 
develop a prevention strategy against prostate 
cancer. Our study revealed that a high percentage 
of publications (about 3%) on cancer, cited in the 
PubMed, are related with prostate (see Table 1). 
The analysis of the number of publications found 
in the PubMed related with the possible types of 
treatment of prostate cancer has shown that 
surgery is more studied than the other treatment 
modalities of this disease. This could be related to 
the fact that the treatment modality of choice for 
prostate cancer depend on the stage of the disease, 
the age of the individual and the presence of other 
clinical conditions. As a consequence, in general, 
if prostate cancer is detected early, treatment 
usually involves radical retropubic prostatectomy 
(Escudero et al., 2006; Kibel et al., 2007). The 
improvement of the assays for early detection of 
prostate cancer has thus favored the use of surgery, 
as a curative modality to treat prostate cancer. 
Thus, although other modalities, such as 
brachytherapy, have come to focus lately with 
particular applications on prostate cancer, surgery 
has been and remains the more cited therapeutic 
approach for prostate cancer (see Tables 2 and 4). 
Yet, more scientific studies about the use of 
radiotherapy in the treatment of the prostate could 
come into focus due to the variety of possible 
sources of radiation (Marshall, 2007; Fang et al., 
2008; Ganswindt et al., 2008) and the potential 
they offer to reduce the number/intensity of 
complications associated with surgery. With 
regards to such trends, it is interesting to note that, 
although hormone therapy had 5 times more 
publications than radiotherapy in Jul 1968, it had 
twice as many in 1978 and 1988 and has the same 
or slightly less publications in Jul 2008, showing a 
smaller rate of increase in this field. On the other 
hand, chemotherapy had the same number of 
publications with radiotherapy in 1968 but nearly 
twice as many in 1978 and 1988, a period of peak 
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for medicinal chemistry, with the gap slowly 
decreasing in more recent years.  
Escudero et al. (2006) and Zagar et al. (2007) have 
reported that such complications as urinary 
incontinence or erectile dysfunction can be 
associated with some treatment modalities of 
prostate cancer. The anal (fecal) incontinence is 
also cited as a complication of the treatment of 
prostate cancer, although its reference in current 
literature is minimal. Furthermore, the undesirable 
complications of urinary incontinence and erectile 
dysfunction have been associated mainly with 
surgery and radiotherapy treatments. The ratio 
(erectile dysfunction/urinary incontinence) 
between these two modalities of treatment was 
1.30 to radiotherapy and 0.93 to surgery. However, 
the ratios are very different if one considers 
chemotherapy (3.69) and hormone therapy (3.91). 
In conclusion, these findings have shown the 
relevance of PubMed in the quantitative analysis 
of publications in cancer, although caution should 
be recommended on the way the searches are 
preformed due to discrepancies in data obtained by 
using different expressions of the same search 
terms. This information could be valuable for the 
comprehension of clinical aspects related to 
prostate cancer, as well as the development of 
preventative actions. The analysis of the scientific 
interest, considering publications in the PubMed, 
shows the importance of surgical procedures in the 
treatment of prostate cancer. This finding is 
relevant due to the fact that surgery is also the 
indicated treatment for prostate cancer at the early 
stages (following early detection). However, it is 
important to consider clinical complications, such 
as urinary incontinence and erectile dysfunctions, 
which can reduce the quality of life of the patient. 
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RESUMO 
 
O câncer (CA) de próstata (PT) é um dos 
neoplasmas malignos mais comuns no homem no 
mundo todo. Em geral, se o câncer de próstata 
(PC) é detectado tardiamente, o tratamento 
usualmente envolve ou a remoção cirúrgica da 
próstata ou radioterapia (RT). Tratamento por 
hormônio (HT) ou quimioterapia (CH) é o 
preferido para muitos casos avançados de PC ou se 
o CA se distribuir além da PT. As complicações 
como incontinência urinária (IU) ou disfunção 
erétil (ED), podem ser associadas com algumas 
modalidades de tratamento do câncer de próstata. 
O objetivo desse trabalho foi avaliar, no PubMed, 
o número de publicações relacionado com câncer 
de próstata e algumas modalidades de tratamento, 
como também algumas complicações clínicas. A 
pesquisa foi realizada no PubMed 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) 
no período de 1950 à 2008 usando as palavras: (i) 
CA, (ii) CA e PR ou penis ou testis, (iii) CA e PR 
e RT, CA e PR e surgery (SU), CA e PR e CH e, 
CA e PR e HT, (iv) CA e PR e RT e IU ou ED, 
CA e PR e SU e IU ou ED, CA e PR e CH e IU ou 
ED e, CA e PR e HT e CH e IU ou ED, e (V) PC e 
as mesmas modalidades de tratamento. O resultado 
foi obtido em 20/07/ 2008.  O câncer de próstata 
tem sido muito citado tanto quanto a cirurgia é a 
modalidade de tratamento e incontinência urinária 
e disfunção erétil são importantes complicações.  
Concluindo, esses achados tem mostrado a 
relevância do PubMed para analisar 
quantitativamente as publicações em câncer e 
essas informações poderiam ser de valor e ajudar 
na compreensão de alguns aspectos clínicos 
relacionados com o câncer de próstata, assim 
como o desenvolvimento de ações preventivas. A 
análise do interesse científico, considerando as 
publicações no PubMed, mostram a importância 
dos procedimentos cirúrgicos no tratamento do 
câncer de próstata. Além disso, esse resultado é 
relevante devido à cirurgia ser também o 
tratamento usado quando é feita uma detecção 
tardia do câncer de próstata. Embora, seja 
importante considerar as complicações clínicas, 
como a incontinência urinária e a disfunção erétil 
que podem reduzir a qualidade de vida do homem. 
Palavras-chaves: câncer de próstata, radioterapia, 
PubMed, interesse científico. 
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